Patent AT-E399554-T1: [Translated] PHARMACEUTICAL COMPOSITION CONTAINING TADALAFIL

Description

Formulations containing a PDE5 inhibitor, a water-soluble diluent, a hydrophilic binder, a disintegrant, and optional microcrystalline cellulose and/or a wetting agent, and their use in treating sexual dysfunction.

Resources

Name Format Description Link
21 Access the complete Patent AT-E399554-T1: [Translated] PHARMACEUTICAL COMPOSITION CONTAINING TADALAFIL on the official website. https://pubchem.ncbi.nlm.nih.gov/patent/AT-E399554-T1

Tags

  • patent
  • chemistry
  • research
  • innovation
  • pubchem

Topics

Categories